Test of a Weight Gain Prevention Intervention in Stage II and III Breast Cancer Patients Receiving Neoadjuvant Chemotherapy

Cancer Epidemiology Biomarkers and Prevention - United States
doi 10.1158/1055-9965.epi-19-3-aspo12
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Occult Tumor Cell Contamination in Patients With Stage II/III Breast Cancer Receiving Sequential High-Dose Chemotherapy

Bone Marrow Transplantation
TransplantationHematology
2003English

Local Radiotherapy Alone Following Neoadjuvant Chemotherapy and Surgery in Combined Clinical Stage II and III Breast Cancer

Radiation Oncology
Nuclear MedicineRadiologyImagingOncology
2016English

Long-Term Prognostic and Predictive Factors in 107 Stage II/III Breast Cancer Patients Treated With Anthracycline-Based Neoadjuvant Chemotherapy

British Journal of Cancer
Cancer ResearchOncology
1997English

Incidence of Chemotherapy-Induced Neutropenia in HIV-infected and Uninfected Patients With Breast Cancer Receiving Neoadjuvant Chemotherapy

South African Medical Journal
Medicine
2017English

2-Year Single Center Clinical Experience in Patients With Colon Cancer Stage II and III Receiving Adjuvant Chemotherapy

Scripta Scientifica Medica
2015English

Actual Conversion Rate From Total Mastectomy to Breast Conservation After Neoadjuvant Chemotherapy for Stages II–III Breast Cancer Patients

Journal of Breast Disease
2017English

Neoadjuvant Chemotherapy in Breast Cancer

English

Gastrointestinal Symptoms and Weight Loss in Cancer Patients Receiving Chemotherapy

British Journal of Nutrition
MedicineNutritionDietetics
2012English

Pneumocystis Jirovecii Pneumonia in a Patient With Breast Cancer Receiving Neoadjuvant Dose-Dense Chemotherapy

Internal Medicine
Internal MedicineMedicine
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy